Thailand says AstraZeneca asked to delay delivery of 61 million vaccine doses | Inquirer News

Thailand says AstraZeneca asked to delay delivery of 61 million vaccine doses

/ 04:06 PM July 15, 2021

Empty vials of Oxford/AstraZeneca's COVID-19 vaccine are seen at a vaccination centre in Antwerp, Belgium March 18, 2021.

 Empty vials of Oxford/AstraZeneca’s COVID-19 vaccine REUTERS FILE PHOTO

BANGKOK — AstraZeneca has asked Thailand to extend the timeline for the delivery of 61 million doses of its COVID-19 vaccine by five months, a deputy minister said on Thursday, a move likely to disrupt further the country’s sluggish vaccine rollout.

Deputy Health Minister Sathit Pitutacha said AstraZeneca currently had the capacity to produce 15 million doses of vaccine per month at its production facility in Thailand and that capacity could expand in the future.

Article continues after this advertisement

AstraZeneca did not immediately respond to a request for comment on Sathit’s statement made during an interview on the MCOT television station.

FEATURED STORIES

But the company seeking to delay delivery points to a slow production ramp-up at its local manufacturing partner, which had initial production and delivery issues, even as AstraZeneca reassured it would be back on track from this month to meet its supply commitments to Thailand and other Southeast Asian nations.

AstraZeneca had promised to deliver 40% of what is produced to Thailand, Sathit said, adding that Thailand will ask the company for more doses.

Article continues after this advertisement

“We must negotiate with them, because in this situation we need more vaccine,” Sathit said.

Article continues after this advertisement

“We want 10 million doses because the original plan was 10 million doses,” he said referring to the previous monthly delivery target.

Article continues after this advertisement

Thailand on Wednesday said it was considering imposing limits on exports of locally manufactured AstraZeneca COVID-19 vaccine to fight its own outbreak.

Responding to a request for comment on the proposal to restrict exports, AstraZeneca said on Wednesday its Thai-manufactured vaccine “is of critical importance” to neighboring countries where the pandemic is also accelerating.

Article continues after this advertisement

“We are actively working with the government in Thailand and governments across Southeast Asia to continue to deliver equitable vaccine access to the region,” the statement said.

Thailand is suffering its worst CVOID-19 outbreak yet and reported a record 98 coronavirus deaths on Thursday taking total fatalities to 3,032 since the pandemic began last year.

The country’s COVID-19 taskforce also reported 9,186 new coronavirus cases, bringing total infections to 372,215.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Thailand’s main vaccine rollout started last month and only about 5% of its more than 66 million people have been fully vaccinated.

TAGS: AstraZeneca, Health, Thailand

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.